## Clinical Diagnosis: Graves' Disease ### Key Clinical Features **Key Point:** The combination of diffuse thyroid enlargement, exophthalmos (lid lag and prominent eyes), and positive TPO antibodies in a young woman with thyrotoxicosis is pathognomonic for Graves' disease. ### Diagnostic Criteria Met | Feature | Finding | Significance | |---------|---------|---------------| | **Thyroid appearance** | Diffusely enlarged, no nodules | Autoimmune thyroiditis, not nodular disease | | **Ophthalmologic signs** | Lid lag, exophthalmos | Unique to Graves' (TSH receptor antibodies in orbital fibroblasts) | | **Antibodies** | TPO antibodies positive | Autoimmune thyroid disease | | **Age & sex** | 32-year-old woman | Graves' 5–10× more common in women; peak 30–50 years | | **TSH suppression** | TSH 0.01 (markedly suppressed) | Consistent with primary hyperthyroidism | | **Elevated free T4 & T3** | Both elevated | Indicates true thyrotoxicosis | ### Pathophysiology 1. **TSH receptor antibodies** (TRAb) bind to TSH receptor on thyroid follicular cells 2. Stimulate continuous thyroid hormone synthesis and release (unlike TSH regulation) 3. **Orbital involvement:** TRAb cross-react with TSH receptors on orbital fibroblasts and adipocytes → inflammation, edema, and exophthalmos 4. Result: Diffuse, firm, hyperactive thyroid gland **High-Yield:** Exophthalmos is **pathognomonic for Graves'** among causes of thyrotoxicosis. No other cause of hyperthyroidism produces orbital inflammation. ### Why TPO Antibodies Are Present **Clinical Pearl:** TPO antibodies are found in ~80% of Graves' disease patients due to concurrent autoimmune thyroiditis. However, **TRAb (TSH receptor antibodies)** are the primary driver of Graves' and would be the gold-standard test if available (not routinely done in all labs). ### Differential Exclusion **Toxic multinodular goiter:** Would show nodular thyroid on palpation/imaging; no exophthalmos; typically older patients. **Thyroiditis:** Transient thyrotoxicosis from follicular rupture; would show low radioactive iodine uptake (not given, but clinical course would be self-limited). **TSH-secreting adenoma:** Would have **elevated TSH** with elevated free T4 (suppressed TSH rules this out).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.